We previously showed that RUNX2 isoform I is the only expressed in cancer and that the RUNX2-P2 transcriptional activity in thyroid and breast cancer is regulated by its interaction with one proximal (ENH3) and two distal (ENH11 and ENH13) enhancers (ENHs) [20, 22]. Here, SOX9 is linked to breast carcinoma.